These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18853077)

  • 1. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
    Wozel G; Vitéz L; Meurer M
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):133-6. PubMed ID: 18853077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
    Wozel G; Vitez L
    Acta Derm Venereol; 2008; 88(2):169-70. PubMed ID: 18311451
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of hand and foot psoriasis with infliximab.
    Di Lernia V; Guareschi E
    Dermatol Online J; 2010 Jul; 16(7):8. PubMed ID: 20673536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study.
    Bissonnette R; Poulin Y; Guenther L; Lynde CW; Bolduc C; Nigen S
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1402-8. PubMed ID: 21349113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a review.
    Kamili QU; Miner A; Hapa A; Menter A
    J Drugs Dermatol; 2011 May; 10(5):539-44. PubMed ID: 21533302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term management of generalized pustular psoriasis with infliximab: case series.
    Routhouska SB; Sheth PB; Korman NJ
    J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term colchicine for recalcitrant palmoplantar pustulosis: treatment outcome in 3 patients.
    Wong SS; Tan KC; Goh CL
    Cutis; 2001 Sep; 68(3):216-8. PubMed ID: 11579788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of Von Zumbusch pustular psoriasis with infliximab.
    Trent JT; Kerdel FA
    J Cutan Med Surg; 2004; 8(4):224-8. PubMed ID: 16091999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four cases.
    Pinter A; Wilsmann-Theis D; Peitsch WK; Mössner R
    J Dermatol; 2019 May; 46(5):426-430. PubMed ID: 30786053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials.
    Brimhall AK; King LN; Licciardone JC; Jacobe H; Menter A
    Br J Dermatol; 2008 Aug; 159(2):274-85. PubMed ID: 18547300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
    Skrabl-Baumgartner A; Weger W; Salmhofer W; Jahnel J
    Pediatr Dermatol; 2015; 32(1):e13-4. PubMed ID: 25644044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis.
    Morales-Múnera C; Vilarrasa E; Puig L
    Br J Dermatol; 2013 Apr; 168(4):820-4. PubMed ID: 23210683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options for palmoplantar pustulosis.
    Adişen E; Gürer MA
    Clin Exp Dermatol; 2010 Apr; 35(3):219-22. PubMed ID: 19874337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab in the management of palmoplantar psoriasis.
    Ghate JV; Alspaugh CD
    J Drugs Dermatol; 2009 Dec; 8(12):1136-9. PubMed ID: 20027943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.
    Gisondi P; Giglio MD; Girolomoni G
    J Dermatolog Treat; 2006; 17(3):172-5. PubMed ID: 16854760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab- and methotrexate-resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva).
    Thielen AM; Barde C; Saurat JH
    Br J Dermatol; 2006 Oct; 155(4):846-7. PubMed ID: 16965444
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab then efalizumab, the 'hit and run' approach does not work.
    Barde C; Thielen AM; Saurat JH
    Dermatology; 2008; 216(2):171-2. PubMed ID: 18216482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blasch-kolinear psoriasis revealed by infliximab therapy].
    Sfia M; Roth-Mall B; Tortel MC; Guillaume JC; Cribier B
    Ann Dermatol Venereol; 2009 Dec; 136(12):898-903. PubMed ID: 20004317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab in recalcitrant generalized pustular arthropatic psoriasis.
    Vieira Serrão V; Martins A; Lopes MJ
    Eur J Dermatol; 2008; 18(1):71-3. PubMed ID: 18086593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.